Search results

Technologies 4

• Placental Accreta Spectrum Diagnostic
  Placenta accreta spectrum (PAS) is a condition where the placenta attaches too deeply into the uterine wall, causing severe bleeding and complications for the mother. PAS occurs in 1 in 300 to 500 deliveries — a 10-fold increase in the past 50 years. However, more than 50% of cases are not detected before delivery. To...
• Fistula Repair: Minimally-Invasive Repair of Obstetric Fistula
  Obstetric fistula is a devastating condition characterized by an abnormal connection between the female genital tract and the bladder or rectum. It affects more than two million women in Africa and Asia and leads to constant leakage of blood, urine, and stool, causing pain, infection, social ostracization, and physical isolation. Current treatment through reconstructive surgery...
• OvaVasc: Enhanced Ovarian Tissue Engraftment for Fertility
  Nearly 80% of women who survive cancer go on to struggle with fertility. Our team is developing an innovative approach using ovarian tissue cryopreservation: freezing and storing ovarian tissue to preserve fertility potential. By combining patient-derived cells and innovative techniques, we are accelerating tissue engraftment, boosting pregnancy rates, and preserving vital ovarian function. Our multidisciplinary...
• CRISPR-Based Vaginal Microbiota Diagnostic
  Despite the clear biological impact of the vaginal microbiome on women’s health, there are no practical diagnostics for vaginal bacterial composition, which limits clinical care and research. We plan to develop a rapid diagnostic platform to identify key vaginal microbial community members and categorize its diversity, enabling researchers and clinicians to better understand variations in...